Dr. Fleshner's clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis.
Cancer Manag Res. 2019;11:10043-10050
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome.
Cancer Manag Res. 2019;11:9307-9319
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.
Eur Urol. 2019 Nov 07;:
Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered a "Negative Core" in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis.
Urology. 2019 Nov 06;:
Incorporating mpMRI biopsy data into established pre-RP nomograms: potential impact of an increasingly common clinical scenario.
Ther Adv Urol. 2019 Jan-Dec;11:1756287219882809
Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer.
Can Urol Assoc J. 2019 Jun 17;:
Comparison of MRI- and TRUS-Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy-Naive Men: A Systematic Review and Meta-Analysis.
J Urol. 2019 Oct 14;:101097JU0000000000000595
Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer Patients.
J Mol Diagn. 2019 Oct 09;:
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Can Urol Assoc J. 2019 Oct;13(10):307-314
Martin Barkin Chair, Division of Urology, Department of Surgery, University of Toronto
Professor, Department of Surgery, University of Toronto